We reasoned that since IFN activity is characteristic for SLE57–60, SLE patients would mimic the 3 h pathogen-stimulation state in which high IFN activity seems to drive the observed CLEC12A co-expression QTL effects. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.